COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

February 21, 2022 00:24:01
Episode Cover

Ketamine or Etomidate for RSI?

Etomidate and ketamine are frequently used for RSI in critically ill patients.  Recent articles have raised concern about an increased incidence of post-intubation hypotension...

Listen

Episode 0

April 17, 2019 00:22:01
Episode Cover

Tips for the Renal Transplant Patient

Renal transplants are one of the most common organ transplants worldwide.  Renal transplant patients can quickly succumb to illness and present to the ED...

Listen

Episode 0

March 08, 2021 00:28:05
Episode Cover

COVID-19 Updates March 2021

In recent weeks, there have been several important studies and guidelines published that have served to improve our understanding of treating critically ill patients...

Listen